Immunotherapy News

Oncolytics Biotech Reports Durable Responses with Pelareorep in RAS-Mutant Colorectal Cancer Trial

2 min

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins as Strategic Adviser for DCVax Cancer Vaccine Development

2 min

Adagene's Muzastotug Shows 66.7% Response Rate in Triple Combination Therapy for Hepatocellular Carcinoma at AACR 2026

2 min

GlycoNex GNX1021 Gets PMDA Approval for First-in-Human Phase 1 Trial in Gastrointestinal Cancers

PMDA · 2 min

CHMP Positive Opinion CAR-T Therapy: What You Need to Know

CHMP (Committee for Medicinal Products for Human Use) · hematology · 7 min